Spanish Society of Hematology and Hemotherapy expert consensus opinion for SARS-CoV-2 vaccination in onco-hematological patients

Autor: Ana Garrido, David Navarro, Rafael de la Cámara, Jose Antonio Pérez Simón, Ramón Lecumberri, Lucrecia Yáñez, Jorge Sierra, Pau Abrisqueta, Angel Cedillo, Maria-Victoria Mateos, Lourdes Vázquez, Anna Torrent, José Luis Piñana, Francesc Bosch, Alberto Alvarez-Larrán, María Díez-Campelo, Rebeca Rodríguez-Veiga, Iván Álvarez-Twose, Alejandro MartínGarcía-Sancho, José-María Ribera, Rodrigo Martino, Juan-Manuel Sancho, Javier de la Rubia, Ramón García-Sanz, Mar Tormo, Anna Sureda, Isabel Ruiz-Camps, Santiago Bonanad, Pere Barba, Valentín García-Gutiérrez, Jose Angel Hernandez-Rivas

Publikováno v: Leukemia & lymphoma
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Leukemia & Lymphoma
article-version (VoR) Version of Record

In the midst of the COVID-19 pandemic, different vaccines in front of SARS-CoV-2 have been approved and administered in different vulnerable populations. As patients with cancer were excluded from pivotal trials of vaccination, little is known on the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a007fe3e96a9952e53d61757f4a299b2
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=14592